Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Intrahepatic Cholangiocarcinoma (Icc) · Gall Bladder Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tia, China
Contact: Study coordinator (Tianjin Medical University Cancer Institute and Hospital Department of Hepatobiliary Cancer) · zhang.wei@tmu.edu.cn · 8618622025401

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)

Intrahepatic Cholangiocarcinoma (Icc) · HAIC · Durvalumab

Abroad (travel likely)RecruitingPHASE2

Chengdu, China

Prospective Evaluation of 68Ga-FAPI PET in Biliary Cancers

Gall Bladder Cancer · Intrahepatic Cholangiocarcinoma (Icc)

Abroad (travel likely)Recruiting

Mumbai, India

A Cell-free DNA Methylation Blood-Based Test for Biliary Tract Cancers Screening

Gall Bladder Cancer · Intrahepatic Cholangiocarcinoma (Icc) · Extrahepatic Cholangiocarcinoma

Abroad (travel likely)Recruiting

Shanghai, China

Cryoablation Combined With Lenvatinib Plus QL1706 (Iparomlimab/Tuvonralimab) in Patients With Advanced Intrahepatic Cholangiocarcinoma

Intrahepatic Cholangiocarcinoma (Icc)

Abroad (travel likely)RecruitingPHASE2

Shanghai, China